Owlstone Medical collaboration with AstraZeneca illustrates applications of breath biopsy kit
It is the latest in a series of developments for diagnostics business Owlstone Medical, which recently brought its breath biopsy kits to market.
It is the latest in a series of developments for diagnostics business Owlstone Medical, which recently brought its breath biopsy kits to market.
The study will seek to determine whether Owlstone Medical's breath biospy tool can match the right patient for the right treatment and to assess the treatment effects of a novel drug for COPD.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Owlstone Medical is working on a breath-based cancer detection system and the hopes is the technology will improve early detection and decrease false positives.